Inspire Medical Systems, Inc. to Report Third Quarter 2018 Financial Results November 6, 2018

Download as PDF

MINNEAPOLIS (October 16, 2018) – Inspire Medical Systems, Inc. (“Inspire”) (NYSE:
INSP), a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea, today announced that it will release financial results for the
third quarter 2018 after the close of trading on Tuesday, November 6, 2018. Inspire’s
management team will host a corresponding conference call beginning at 5:00 p.m. ET
to discuss the financial results and recent business developments.

Tuesday, November 6th @ 5:00pm Eastern Time:
Domestic: 866-575-6539
International: 323-994-2082
Conference ID: 1767102
Webcast: http://public.viavid.com/index.php?id=131698

To listen to a live webcast, please visit the Investors section of the Inspire website at
www.inspiresleep.com. The webcast replay will be available on the Inspire website for
two weeks following the completion of the call.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-
approved neurostimulation technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989